Thursday, March 27, 2008

U.S. reviewing safety of Glaxo, Bristol AIDS drugs

from AlertNet

U.S. health officials are reviewing the safety of AIDS drugs sold by GlaxoSmithKline Plc and Bristol-Myers Squibb Co after a study showed a higher heart attack risk compared with other HIV medicines, the Food and Drug Administration said on Thursday.

Read on